Annual Drug Patent Expirations for ADCIRCA
Adcirca is a drug marketed by Eli Lilly Co and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Copyright © DrugPatentWatch. Originally published at Patent delisted for Eli Lilly drug ADCIRCA